University of Utah
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).
University of Utah: 818 sponsored US clinical trials, 138 recruiting.
University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.
Top-decile sponsor footprint
University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
818 total, page 9 of 17
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
NCT03276676
Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma
NCT03534804
Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects
NCT03466736
Amitriptyline in Treating Hypoglycemia
NCT03591458
Incidence of Diarrhea Using High and Low Osmolality Enteral Tube Feeding in Critically Ill Surgical Patients
NCT03487744
Building Social Skills With Interdisciplinary Process Drama in ASD
NCT03536351
Autophagy Maintains Vascular Function Through a Novel Glycolysis-linked Pathway Regulating eNOS
NCT04200560
Blood and Muscle Response to Cheddar Cheese in Healthy Adults
NCT04660877
Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
NCT03200587
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
NCT03407976
Psychosocial Support for Pre-operative Pain and Distress
NCT03665727
Gaze and Postural Stability in Multiple Sclerosis
NCT03521557
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
NCT03416348
Measuring Postoperative Mobility, Gait Symmetry and Feedback Following TJA
NCT03673293
Serving Women Using Opioids During Pregnancy
NCT03552120
Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma
NCT03382886
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
NCT03303950
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
NCT03516656
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
NCT03532555
The Effect of Electronic Informed Consent Information (EICI) on Residual Newborn Specimen Research
NCT03141307
Group Therapy For Dementia Caregivers At Risk For Complicated Grief
NCT03177772
Noninvasive Measurements of Renal Perfusion During Cardiac Surgery
NCT03335865
Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone
NCT03304418
Fatigue Interventions in Cancer (Exercise Intervention)
NCT03421782
Contrast-Enhanced Ultrasound for Kidney Transplant
NCT02911714
Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)
NCT03215940
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
NCT02317783
Merestinib on Bone Metastases in Subjects With Breast Cancer
NCT03292536
Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma
NCT03259425
The Bronchiolitis Follow-up Intervention Trial
NCT03354325
Does Low-does Cervical Epidural Lidocaine Cause Transient Weakness?
NCT03382925
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
NCT03345420
Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma
NCT03190213
Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas
NCT03392935
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
NCT03339349
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study
NCT03306992
Validation of Frontal EEG to Formal Polysomnography in the ICU
NCT03322371
Audiovisual Distraction for Patients Undergoing Total Knee or Hip Replacement Surgery
NCT03191838
Sleep/Wake Protocol Implementation to Improve Sleep Quality in the ICU
NCT03313115
Behavioral Interventions for Chronic Pain and Opioid-Related Problems
NCT03298269
Community Pharmacists and Opioid Misuse
NCT03149718
Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients
NCT03251963
Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach
NCT03382821
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
NCT01968590
Dissecting De-automatization
NCT03456505
Collaborative Care for Infants at Risk
NCT03199326
SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention
NCT02779725
Short Message Service Based Patient Education in Spine Patients
NCT04458428
Oxandrolone in Healthy Adults: A Relative Bioavailability Study
NCT03218631
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
NCT03212365
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 145 |
| Phase 2 | 123 |
| Phase 3 | 18 |
| Phase 4 | 27 |
Therapeutic Areas
What is open in the University of Utah pipeline
138 recruiting of 818 indexed (17% open); 492 completed (60%).
Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).
Top condition: Low Back Pain (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Utah: open-pipeline peers nationwide
Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 818 trials (± recruiting share)
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- AdventHealth · 17% recruiting · 95 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this University of Utah page
818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.
- 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.